Stay updated on Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference8%
- Check21 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedUpdate: Revision changed from v3.0.1 to v3.0.2; 'Back to Top' link removed. No other substantive content changes detected.SummaryDifference0.5%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.5%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference69%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.